1. Home
  2. EDIT vs WRN Comparison

EDIT vs WRN Comparison

Compare EDIT & WRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDIT
  • WRN
  • Stock Information
  • Founded
  • EDIT 2013
  • WRN 2006
  • Country
  • EDIT United States
  • WRN Canada
  • Employees
  • EDIT N/A
  • WRN N/A
  • Industry
  • EDIT Biotechnology: Biological Products (No Diagnostic Substances)
  • WRN Metal Mining
  • Sector
  • EDIT Health Care
  • WRN Basic Materials
  • Exchange
  • EDIT Nasdaq
  • WRN Nasdaq
  • Market Cap
  • EDIT 263.7M
  • WRN 248.0M
  • IPO Year
  • EDIT 2016
  • WRN N/A
  • Fundamental
  • Price
  • EDIT $2.57
  • WRN $1.43
  • Analyst Decision
  • EDIT Buy
  • WRN Strong Buy
  • Analyst Count
  • EDIT 12
  • WRN 1
  • Target Price
  • EDIT $5.40
  • WRN $4.00
  • AVG Volume (30 Days)
  • EDIT 1.7M
  • WRN 415.5K
  • Earning Date
  • EDIT 08-12-2025
  • WRN 08-08-2025
  • Dividend Yield
  • EDIT N/A
  • WRN N/A
  • EPS Growth
  • EDIT N/A
  • WRN N/A
  • EPS
  • EDIT N/A
  • WRN N/A
  • Revenue
  • EDIT $38,901,000.00
  • WRN N/A
  • Revenue This Year
  • EDIT N/A
  • WRN N/A
  • Revenue Next Year
  • EDIT N/A
  • WRN N/A
  • P/E Ratio
  • EDIT N/A
  • WRN N/A
  • Revenue Growth
  • EDIT N/A
  • WRN N/A
  • 52 Week Low
  • EDIT $0.91
  • WRN $0.90
  • 52 Week High
  • EDIT $4.12
  • WRN $1.44
  • Technical
  • Relative Strength Index (RSI)
  • EDIT 46.57
  • WRN 65.80
  • Support Level
  • EDIT $2.66
  • WRN $1.20
  • Resistance Level
  • EDIT $2.78
  • WRN $1.44
  • Average True Range (ATR)
  • EDIT 0.22
  • WRN 0.06
  • MACD
  • EDIT -0.02
  • WRN 0.02
  • Stochastic Oscillator
  • EDIT 39.39
  • WRN 95.83

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

About WRN Western Copper and Gold Corporation

Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project).

Share on Social Networks: